FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates

Byoung-Chul Lee1, Cecile Chalouni2, Sophia Doll1,2

  • 1Department of Protein Chemistry , Genentech, Inc. , 1 DNA Way , South San Francisco , California 94080 , United States.

Insights

This study reveals that cellular background impacts antibody-drug conjugate (ADC) processing and payload delivery. A novel FRET assay offers robust assessment of intracellular ADC activation for improved cancer therapy development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Therapy

Background:

  • Antibody-drug conjugates (ADCs) are successful cancer therapeutics.
  • Intracellular trafficking and metabolism of ADCs remain incompletely understood.
  • Understanding ADC activation is crucial for optimizing drug development.

Purpose of the Study:

  • To investigate the intracellular processing and trafficking of ADCs.
  • To develop a method for assessing ADC activation within cells.
  • To explore the influence of cellular background on ADC mechanisms.

Main Methods:

  • Incorporation of fluorescence resonance energy transfer (FRET) reporter groups into ADC linkers.
  • Comparative analysis of antibody-FRET drug conjugate trafficking in diverse model cell lines.
  • Assessment of intracellular payload transport and linker cleavage.

Main Results:

  • Cellular background significantly influences antigen-mediated antibody processing.
  • Limited cytosolic transport of drug payload observed in some tumor cells, despite efficient linker cleavage.
  • The FRET assay demonstrated a facile and robust method for evaluating intracellular ADC activation.

Conclusions:

  • Cellular context is a critical factor in ADC efficacy.
  • The developed FRET assay is a valuable tool for studying ADC intracellular dynamics.
  • This research provides insights for the future design and development of novel ADCs for cancer treatment.

Related Concept Videos

Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.4K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
28.9K
Conjugated Proteins02:50

Conjugated Proteins

3.2K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.7K